Clinical Trial: Genetic Identification (ID) of Segmental Dysplastic Nevi
Study Status: Active, not recruiting
Recruit Status: Unknown status
Study Type: Observational
Official Title: Identification of the Genetic Mutation Responsible for Segmental Dysplastic Nevi
Brief Summary: The investigators' goal is to identify the mutation in the gene that is responsible for the development of segmental dysplastic nevi. To identify the gene the investigators may use a candidate gene approach (i.e. sequence specific genes that are thought to be involved: NRAS, BRAF, etc) or a genome-wide approach trying to implicate regions in the genome (Loss-of-heterozygosity or copy number changes on comparative genomic hybridization).